GlassScriptPhysician profile
John P Shillinglaw
NPI 1154883452
$2,929.13
in general payments reported to CMS, 2019-2025
26 companies · $38.13 in 2025
The $38.13 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $281 · 2021: $372 · 2022: $639 · 2023: $726 · 2024: $511 · 2025: $38.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $706.74 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $642.42 | 2021-2024 | Matrixrib |
| Acell, INC. | $481.12 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $271.29 | 2022-2024 | |
| Kerecis Limited | $104.77 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $92.04 | 2021-2023 | Seprafilm, Floseal |
| Ethicon US, LLC | $81.05 | 2022-2023 | Surgicel Nu-Knit, Harmonic, Vistaseal |
| Avanos Medical | $77.34 | 2019-2021 | |
| Btg International INC. | $62.89 | 2022-2023 | |
| Haemonetics Corporation | $62.44 | 2023-2024 | Teg5000 Hemostasis Analyzer, Teg6s Hemostasis System |
| Chiesi USA, INC. | $40.29 | 2019-2020 | |
| Csl Behring | $37.12 | 2020 | |
| Atricure, INC. | $28.13 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $26.79 | 2021 | |
| Biocomposites INC | $26.38 | 2023 | Stimulan |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $23.58 | 2025 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $20.48 | 2023 | Andexxa |
| Abbott Laboratories | $20.36 | 2024 | I-Stat |
| Lifenet Health | $20.13 | 2024 | Theragenesis Wound Matrix |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Allergan, INC. | $15.95 | 2021 | |
| Endo Pharmaceuticals INC. | $15.90 | 2019 | |
| Prytime Medical Devices, INC. | $14.55 | 2025 | Er-Reboa Plus |
| Heron Therapeutics, INC. | $14.03 | 2021 | |
| Kci USA, INC. | $12.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Shillinglaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.